| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | |
|---|---|---|---|---|---|---|
Assets | ||||||
Current assets: | ||||||
Cash and cash equivalents | ||||||
104,454 | 113,151 | 123,690 | 134,893 | 70,508 | 48,580 | |
Accounts receivable | ||||||
2,811 | 1,537 | 1,266 | 3,256 | 1,328 | 4,919 | |
Receivable research incentives | ||||||
9,296 | 8,190 | - | - | - | 2,329 | |
Prepaid expenses and other current assets | ||||||
4,155 | 5,139 | 11,430 | 12,951 | 13,067 | 6,483 | |
Total current assets | ||||||
120,716 | 128,017 | 136,386 | 151,100 | 84,903 | 62,311 | |
Non-current assets: | ||||||
Restricted cash | ||||||
400 | 424 | 300 | 300 | - | - | |
Property and equipment, net | ||||||
5,429 | 5,126 | 4,607 | 4,579 | 4,512 | 4,337 | |
Operating lease right of use assets | ||||||
7,286 | 7,875 | 8,127 | 8,909 | 8,920 | - | |
Finance lease right of use assets | ||||||
1,471 | 1,602 | - | - | - | - | |
Other non-current assets | ||||||
642 | 701 | 2,597 | 3,187 | 3,645 | 1,603 | |
Total non-current assets | ||||||
15,251 | 15,728 | 15,651 | 16,995 | 17,077 | 5,940 | |
Total assets | ||||||
135,967 | 143,745 | 152,037 | 168,095 | 101,980 | 68,251 | |
Liabilities and Stockholders’ Equity (Deficit) | ||||||
Current liabilities | ||||||
Accounts payable | ||||||
4,044 | 944 | 3,488 | 5,095 | 3,298 | 3,656 | |
Deferred revenues | ||||||
5,360 | 3,591 | 4,239 | 5,225 | 6,368 | 6,619 | |
Operating lease liabilities, current | ||||||
1,798 | 1,814 | - | - | - | - | |
Accrued expenses and other current liabilities | ||||||
4,183 | 8,406 | 5,227 | 7,063 | 5,428 | 4,420 | |
Total current liabilities | ||||||
15,385 | 14,755 | 12,954 | 17,383 | 15,094 | 14,695 | |
Non-current liabilities | ||||||
Loans payable, non-current | ||||||
3,586 | 3,495 | 4,766 | 4,754 | 4,499 | 4,392 | |
Operating lease liabilities, non-current | ||||||
4,799 | 5,290 | 5,558 | 6,177 | 6,311 | - | |
Deferred revenues, non-current | ||||||
1,254 | 72 | 377 | 715 | 823 | 1,663 | |
Other non-current liabilities | ||||||
1,961 | 2,234 | 2,625 | 3,033 | 3,262 | 3,102 | |
Total non-current liabilities | ||||||
11,600 | 11,091 | 13,326 | 14,679 | 14,895 | 9,157 | |
Total liabilities | ||||||
26,985 | 25,846 | 26,280 | 32,062 | 29,989 | 23,852 | |
Redeemable convertible preferred stock (series A, B, C and D), $0.0001 par value; 0 and 1,323,506 shares authorized, issued and outstanding at December 31, 2019 and December 31, 2018, respectively; aggregate liquidation preference of $0.0 million and $99.7 million at December 31, 2019 and December 31, 2018, respectively | ||||||
- | - | - | - | 142,048 | 104,774 | |
Stockholders’ equity (deficit): | ||||||
Common stock | ||||||
- | - | - | 3 | 0 | - | |
Additional paid-in capital | ||||||
227,670 | 225,568 | 223,448 | 221,576 | 3,710 | 3,327 | |
Accumulated other comprehensive loss | ||||||
-4,746 | -4,653 | -4,919 | -4,156 | -4,457 | -3,720 | |
Accumulated deficit | ||||||
-113,900 | -103,019 | -92,800 | -81,400 | -69,310 | -59,982 | |
Total stockholders’ equity (deficit) | ||||||
108,982 | 117,899 | 125,757 | 136,033 | -70,057 | -60,375 | |
Total liabilities, convertible preferred stock and stockholders’ equity (deficit) | ||||||
135,967 | 143,745 | 152,037 | 168,095 | 101,980 | 68,251 | |
Common stock | ||||||
Common stock | ||||||
3 | 3 | 3 | - | - | 0 | |
Class A common stock | ||||||
Common stock | ||||||
0 | 0 | 0 | 0 | - | - | |